Treatment of familial male precocious puberty with spironolactone and testolactone

The New England Journal of Medicine
L LaueG B Cutler

Abstract

Because the pubertal growth spurt in boys appears to be mediated by both androgens and estrogens, we hypothesized that blockade of both androgen action and estrogen synthesis would normalize the growth of boys with familial male precocious puberty. To test this hypothesis, we studied nine boys (age range, 3.3 to 7.7 years) during treatment with an antiandrogen (spironolactone) or an inhibitor of androgen-to-estrogen conversion (testolactone), followed by treatment with both agents. After six months of observation without treatment, the first four boys received spironolactone for six months, followed by spironolactone and testolactone. The next five boys received testolactone for six months, followed by spironolactone and testolactone. Neither spironolactone nor testolactone, given alone, was satisfactory as a treatment for this condition. However, a combination of spironolactone and testolactone, given for at least six months, restored both the growth rate and the rate of bone maturation to normal prepubertal levels and controlled acne, spontaneous erections, and aggressive behavior. The combined therapy was associated with a significantly lower growth rate than testolactone alone (P less than 0.05) and a significantly lower ra...Continue Reading

Associated Clinical Trials

References

Jul 1, 1975·Endocrinology·P CorvolJ Mahoudeau
Nov 1, 1976·Annals of Internal Medicine
Oct 1, 1975·The Journal of Clinical Endocrinology and Metabolism·B StrippR H Menard
Apr 18, 1985·The New England Journal of Medicine·F J HollandA T Fazekas
Aug 1, 1988·The Journal of Clinical Endocrinology and Metabolism·P K ManascoG B Cutler
Feb 1, 1987·The Journal of Clinical Endocrinology and Metabolism·F J HollandR Selby
Sep 1, 1985·The Journal of Pediatrics·J M Tanner, P S Davies
Jan 10, 1985·The New England Journal of Medicine·M E WiermanR E Scully
Nov 1, 1985·The Journal of Clinical Endocrinology and Metabolism·M Caruso-NicolettiG B Cutler
Feb 1, 1967·The Journal of Clinical Investigation·W D OdellP L Rayford
Oct 1, 1983·The Journal of Clinical Endocrinology and Metabolism·R J SantenR DeCoster
Feb 1, 1984·Acta Endocrinologica·T Schürmeyer, E Nieschlag
Oct 1, 1984·The Journal of Clinical Endocrinology and Metabolism·C M FosterG B Cutler
Apr 1, 1984·The Journal of Clinical Endocrinology and Metabolism·F G CassorlaD L Loriaux
Nov 3, 1983·The New England Journal of Medicine·J L RossG B Cutler
Feb 1, 1981·The Journal of Clinical Endocrinology and Metabolism·H K SchedewieM J Elders

❮ Previous
Next ❯

Citations

Nov 1, 1991·Medicinal Research Reviews·W Sutanto, E R de Kloet
Mar 24, 1995·Pharmacy World & Science : PWS·W Sutanto, E R de Kloet
Apr 1, 1994·European Journal of Pediatrics·Y J Lim, L C Low
Jul 4, 2006·Indian Journal of Pediatrics·R RajputR Sialy
Apr 1, 1992·Baillière's Clinical Endocrinology and Metabolism·R S SwerdloffS Bhasin
Apr 15, 2008·Trends in Endocrinology and Metabolism : TEM·R M Sharpe
Dec 27, 1990·The New England Journal of Medicine·G B Cutler, L Laue
Feb 3, 1991·The New England Journal of Medicine·P K ManascoB D Albertson
Oct 20, 1994·The New England Journal of Medicine·E P SmithK S Korach
Mar 14, 1995·Proceedings of the National Academy of Sciences of the United States of America·L LaueG B Cutler
Sep 1, 1994·Acta Paediatrica·D Babovic-VuksanovicA M Wallace
Oct 1, 1996·Acta Paediatrica. Supplement·E P Smith, K S Korach
Oct 1, 1996·Archives of Disease in Childhood·D P Merke, G B Cutler
May 13, 1999·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·X Z ZhangE Seeman
Jul 20, 2005·Treatments in Endocrinology·Erica A Eugster
May 26, 2012·Indian Journal of Endocrinology and Metabolism·Bindu KulshreshthaAriachery C Ammini
Sep 3, 2010·European Journal of Endocrinology·Sven C MuellerDeborah P Merke
Aug 29, 2013·European Journal of Pediatrics·Yvonne Yijuan LimYung Seng Lee
May 10, 2001·Endocrinology and Metabolism Clinics of North America·D P Merke, G B Cutler
May 10, 2001·Endocrinology and Metabolism Clinics of North America·P W Speiser
Apr 1, 1997·The Journal of Steroid Biochemistry and Molecular Biology·G B Cutler
Jan 16, 2007·Current Problems in Pediatric and Adolescent Health Care·Todd D Nebesio, Erica A Eugster
Dec 20, 2007·Clinical Endocrinology·Madson Queiroz AlmeidaAna Claudia Latronico
Sep 11, 2010·The Anatomical Record : Advances in Integrative Anatomy and Evolutionary Biology·Angela C Bauer-Dantoin, Daniel J Meinhardt
Jun 13, 2006·Molecular and Cellular Endocrinology·Leo Dunkel
Jul 1, 1992·The Journal of Pediatrics·C PotterS J Scharzenberg
Mar 5, 2002·Clinical Endocrinology·Carl-Joachim PartschWolfgang G Sippell
Apr 25, 2001·Clinical Endocrinology·A BalestrieriC Carani
Jan 1, 1994·Clinical Pediatrics·P A Lee
Oct 26, 2011·Nature Reviews. Endocrinology·Jan M WitSusan B Nunez
Jul 18, 2003·Medical and Pediatric Oncology·Graeme R Frank
Mar 1, 1992·Postgraduate Medical Journal·A A AzizN U Haque
Oct 6, 2005·Hormone Research·Ola NilssonJeffrey Baron
Oct 30, 1998·Endocrine Reviews·S L DropS M De Muinck Keizer-Schrama
Mar 1, 2006·Expert Review of Endocrinology & Metabolism·Luigi GennariJohn P Bilezikian
Mar 20, 1998·The Journal of Clinical Endocrinology and Metabolism·E A CummingsR S Rittmaster
Dec 15, 1989·Hospital Practice·D L Loriaux
Jun 2, 2009·Pediatrics·David B AllenNorman Fost
Apr 3, 2008·Pediatrics·Dorothy I ShulmanUNKNOWN Lawson Wilkins Pediatric Endocrine Society Drug and Therapeutics Committee
Aug 18, 2010·Pediatrics·Anne M LenzKatherine A Lewis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved